Edap Tms (NASDAQ:EDAP) Downgraded to Hold at ValuEngine – TechNewsObserver

ValuEngine lowered shares of Edap Tms (NASDAQ:EDAP) from a buy rating to a hold rating in a research report released on Saturday, August 31st, ValuEngine reports.

Other research analysts have also issued research reports about the stock. HC Wainwright set a $7.00 price target on shares of Edap Tms and gave the stock a buy rating in a research report on Tuesday, June 11th. TheStreet lowered shares of Edap Tms from a b- rating to a d+ rating in a report on Monday, June 17th. Finally, Zacks Investment Research raised shares of Edap Tms from a sell rating to a hold rating in a report on Tuesday, July 16th.

Shares of EDAP traded up $0.08 during trading hours on Friday, reaching $4.08. 119,357 shares of the company traded hands, compared to its average volume of 109,650. Edap Tms has a 1-year low of $1.35 and a 1-year high of $5.42. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.97 and a current ratio of 2.40. The stock has a market cap of $115.41 million, a P/E ratio of 204.00 and a beta of 1.87. The stocks fifty day moving average is $3.24 and its 200 day moving average is $3.37.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported $0.05 earnings per share (EPS) for the quarter, topping the Thomson Reuters consensus estimate of $0.01 by $0.04. Edap Tms had a net margin of 4.57% and a return on equity of 23.31%. The firm had revenue of $14.04 million during the quarter, compared to analyst estimates of $11.92 million. On average, equities research analysts predict that Edap Tms will post 0.18 EPS for the current year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Fosun International Ltd grew its stake in shares of Edap Tms by 9.4% during the second quarter. Fosun International Ltd now owns 397,568 shares of the medical equipment providers stock valued at $1,145,000 after purchasing an additional 34,083 shares during the last quarter. Morgan Stanley boosted its stake in Edap Tms by 222.7% in the second quarter. Morgan Stanley now owns 267,408 shares of the medical equipment providers stock valued at $722,000 after acquiring an additional 184,539 shares during the last quarter. Acadian Asset Management LLC bought a new position in Edap Tms in the second quarter valued at approximately $607,000. Susquehanna International Group LLP boosted its stake in Edap Tms by 762.9% in the second quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment providers stock valued at $556,000 after acquiring an additional 181,401 shares during the last quarter. Finally, JPMorgan Chase & Co. bought a new position in Edap Tms in the second quarter valued at approximately $282,000. 13.24% of the stock is currently owned by institutional investors and hedge funds.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).

Featured Story: Cryptocurrencies

To view ValuEngines full report, visit ValuEngines official website.

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.

See the original post here:

Edap Tms (NASDAQ:EDAP) Downgraded to Hold at ValuEngine - TechNewsObserver